Nkarta Inc
NKTX
NASDAQ
Biotechnology
$2.33
USD
+0.03 (+1.30%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $164.38M
Volume 302.4K
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
CHRS | Coherus Oncology Inc | $176.13M | - | -64.3% | - | |
NKTX | Nkarta Inc | $164.38M | - | - | - | |
TNYA | Tenaya Therapeutics Inc | $164.36M | - | - | - | |
CNTB | Connect Biopharma Holdings Ltd | $159.93M | - | - | - | |
CRBU | Caribou Biosciences Inc | $159.68M | - | +13.0% | - | |
OKUR | Onkure Therapeutics Inc | $157.94M | - | - | - | |
CNTN | Canton Strategic Holdings Inc | $151.93M | - | - | - | |
HUMA | Humacyte Inc | $148.30M | - | +231.7% | - | |
HURA | TuHURA Biosciences Inc | $147.11M | - | - | +0.0% |
Top Peer by Growth
Humacyte Inc
+231.7% YoY Revenue
Best 1-Year Return
Onkure Therapeutics Inc
+96.5% Return